Thrombocytosis during antifungal therapy of candidemia

Annals of Pharmacotherapy

Volumn 39, Issue 7-8, 2005, Pages 1238-1243

  Saathoff, Angela D ^a   Elkins, Stephanie L ^a   Chapman, Stanley W ^a   McAllister, Susan Fleming ^a   Cleary, John D ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Antifungal therapy; candidemia; Thrombocytosis

Indexed keywords

ACICLOVIR; ADRENALIN; ALCOHOL; AMOXICILLIN; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ARYLBUTYRIC ACID DERIVATIVE; AZTREONAM; CASPOFUNGIN; CEFDITOREN; CEFMENOXIME; CEFONICID; CEFORANIDE; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CLOZAPINE; CYCLOSPORIN; DANAZOL; DAPSONE; ENOXAPARIN; ERYTHROPOIETIN; ETRETIN; FERROUS SULFATE; FLOMOXEF; FLUCONAZOLE; FLUOCORTOLONE; FLUPIRTINE; IMIPENEM; LAMOTRIGINE; LATAMOXEF; LEFLUNOMIDE; LITHIUM; MECILLINAM; MICONAZOLE; MILTEFOSINE; NIPRADILOL; PEMIROLAST; PIVMECILLINAM; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RETINOIC ACID; ROXITHROMYCIN; SODIUM PHENYLBUTYRATE; SUCCIMER; TASONERMIN; THROMBOPOIETIN; UNCLASSIFIED DRUG; VINCRISTINE; VINDESINE; VORICONAZOLE;

ADULT; AGED; ANAPHYLACTOID PURPURA; ARTICLE; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BLEEDING; CANDIDA; CANDIDEMIA; CANDIDIASIS; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERKALEMIA; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; OVARY HYPERSTIMULATION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATIC FEVER; SICKLE CELL ANEMIA; STROKE; TEMPORAL ARTERITIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CANDIDIASIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOCYTOSIS;

EID: 21744455479     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E402     Document Type: Article

References (24)

1. Murphy S, Peterson P, Iland H, Laszlo J. Experience of the polycythemia vera study group with essential thrombocythemia: a final report on diagnostic criteria, survival and leukemic transition by treatment. Semin Hematol 1997;34:29-39.
2. Rizzieri DA, Wong WM, Gockerman JP. Thrombocytosis associated with low-molecular-weight heparin (letter). Ann Intern Med 1996;125: 157. Erratum 1996;125:861.
3. Numminen H, Hillbom M, Seppo J. Platelets, alcohol consumption, and onset of brain infarction. J Neurol Neurosurg Psychiatry 1996;61:376-80.
4. Griesshammer M, Bangerter M, Sauer T, Wennauer R, Bergmann L, Heimpel H. Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Intern Med 1999;245:295-300.
5. Micromedex Healthcare Series. Greenwood Village, CO: Thomson Micromedex (edition expired 2004).
6. Agarwal A. Fluconazole-induced thrombocytopenia (letter). Ann Intern Med 1990;113:899.
7. Hirsh J, Dacie JV. Persistent post splenectomy thrombocytosis and thromboembolism: a consequence of continuing anaemia. Br J Haematol 1966;12:44-53.
8. Bierman HR, Kelly KH, Cordes FL, Byron L, Polhemus JA, Rappoport S. The release of leukocytes and platelets from the pulmonary circulation by epinephrine. Blood 1952;7:683-92.
9. Deray G, Lejonc JL, Galacteros F, Creteil F. Thrombocytosis as a feature of iron-deficiency therapeutic correction. Arch Intern Med 1984;144: 414-5.
10. Feliu E, Cervantes F, Blade J, Rozman C. Thrombocytosis in quiescent chronic granulocytic leukaemia after vincristine and 6 mercaptopurine therapy. Acta Haemat 1980;64:224-6.
11. Frye JL, Thompson DF. Drug-induced thrombocytosis. J Clin Pharm Ther 1993;18:45-8.
12. Itami N, Akutsu Y, Yasoshima K. Thrombocytosis after cyclosporin therapy in child with nephrotic syndrome (letter). Lancet 1988;2:1018.
13. Planting AST, Stoter G, Verweij J. Phase II study of daily oral miltefosine in advanced colorectal cancer. Eur J Cancer 1993;29:518-9.
14. Losada R, Espinosa E, Hernandez C, Dorticos E, Hernandez P. Thrombocytosis in patients with acute promyelocytic leukaemia during all-trans-retinoic acid treatment. Br J Haemat 1996;95:704-5.
15. Sugar AM, Saunders C. Oral fluconazole as suppressive therapy of disseminated cryptococcus in patients with acquired immunodeficiency syndrome. Am J Med 1988;85:481-9.
16. Joffe RT, Kellner G, Post RM. Lithium increases in platelet counts (letter). N Engl J Med 1984;311:674-5.
17. Gombert ME, Glasser LA, Eng RHK. Cefmenoxime therapy of serious bacterial infections. Antimicrob Agents Chemother 1984;25:510-2.
18. Bechard DL, Hawkins SH, Sutherland SC. Comparative evaluation of cefmenoxime versus cefoxitin in serious infections. Am J Med 1984;77(6A): 13-6.
19. Baumgertner JD, Glauser MP. Comparative study of imipenem in severe infections. J Antimicrob Chemother 1983;12(suppl D):141-8.
20. Corno M, Vallar G, Scarlato G, Meola G. Danazol and internal carotid artery thrombosis. Eur Neurol 1989;29:235-7.
21. Larsen RA, Leal MA, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Ann Intern Med 1990;113:183-7.
22. Saathoff AD, Elkins S, Chapman SW, Cleary JD. Thrombocytosis associated with candidemia and its treatment (abstract 115). In: Program and Abstracts of the Annual Meeting of the American College of Clinical Pharmacy, Atlanta, GA, November 5, 2003.
23. Cleary J, Sullivan D, Wilkins D, Chapman S. Pharmacogenomics of disseminated candidemia (abstract). In: Program and Abstracts of the American Society of Microbiology Conference on Candida, Austin, TX, March 18, 2004.
24. Cazzola M, Skoda RC. Translational pathophysiology: a novel molecular mechanism of human disease. Blood 2000;95:3280-8.